3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Motor Activity
35
Breast Neoplasms
20
Neoplasms
19
Fatigue
9
Prostatic Neoplasms
4
Lung Neoplasms
4
Hematologic Neoplasms
4
Colorectal Neoplasms
4
Obesity
3
Weight Loss
2
Smoking
2
Sedentary Behavior
2
Postoperative Complications
2
Ovarian Neoplasms
2
Mixed Cancer
2
Lymphedema
2
Frailty
2
Colonic Neoplasms
2
Cardiotoxicity
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urologic Neoplasms
1
Urinary Incontinence
1
Stomach Neoplasms
1
Sarcoma
1
Risk Reduction Behavior
1
Rehabilitation After Lung Cancer Surgery
1
Interventions
Gemcitabine
13
Oxaliplatin
9
Capecitabine
6
lenvatinib
5
apatinib
5
Cisplatin
5
tislelizumab
4
Surgical Procedures, Operative
4
Radiofrequency Ablation
4
Neoadjuvant Therapy
4
Fluorouracil
4
toripalimab
3
sintilimab
3
Radiotherapy
3
Leucovorin
3
Irinotecan
3
regorafenib
2
pembrolizumab
2
durvalumab
2
camrelizumab
2
Stents
2
Photochemotherapy
2
Immunotherapy
2
Hepatectomy
2
Folfox protocol
2
Everolimus
2
Drug Therapy
2
Cholangiopancreatography, Endoscopic Retrograde
2
Blood Specimen Collection
2
1-phenyl-3,3-dimethyltriazene
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Cholangiocarcinoma
×
Exercise
×
Clear all
NCT02162914
2020-07-31
REACHIN
Erasme University Hospital
Phase 2
Unknown
66 enrolled